Peter J. Fromen
Chief Executive Officer at Biomodal Ltd.
Peter J. Fromen active positions
| Companies | Position | Start | End |
|---|---|---|---|
Biomodal Ltd.
 Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 2022-07-17 | - |
| Chief Executive Officer | 2022-07-17 | - |
Career history of Peter J. Fromen
Former positions of Peter J. Fromen
| Companies | Position | Start | End |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Corporate Officer/Principal | 2021-01-07 | 2022-05-19 |
| ILLUMINA, INC. | Investor Relations Contact | 2011-06-02 | - |
| Public Communications Contact | 2006-12-31 | 2011-05-23 | |
| Corporate Officer/Principal | - | - | |
| Sales & Marketing | 2011-05-23 | 2011-06-02 |
Training of Peter J. Fromen
| Kenyon College | Undergraduate Degree |
| W.P. Carey School of Business | Masters Business Admin |
Statistics
International
| United States | 5 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Peter J. Fromen
- Experience
